Literature DB >> 22142220

Cytokine homologs of human gammaherpesviruses.

Sang-Hoon Sin1, Dirk P Dittmer.   

Abstract

Gammaherpesviruses such as Epstein-Barr virus (EBV, human herpesvirus 4) and Kaposi sarcoma-associated herpesvirus (KSHV, human herpesvirus 8) establish lifelong infection in the host. To further this lifestyle, they encode homologs of cellular cytokines and cytokine receptors with the overarching goal to escape from or to blunt host antiviral defenses. EBV encodes mimics of human interleukin (hIL)-10 and a G protein-coupled receptor protein with sequence similarity to CXCR, whereas KSHV encodes homologs of hIL-6, 3 CC chemokine ligands, and a G protein-coupled receptor with sequence similarity to IL8 receptor alpha. This review focuses on the EBV IL-10 homolog and the KSHV IL-6 homolog with respect to virus biology and pathogenesis of the virus-associated diseases. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142220      PMCID: PMC3275093          DOI: 10.1089/jir.2011.0083

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  97 in total

1.  A rhesus macaque rhadinovirus related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 encodes a functional homologue of interleukin-6.

Authors:  J A Kaleeba; E P Bergquam; S W Wong
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Epstein-Barr virus-encoded BILF1 is a constitutively active G protein-coupled receptor.

Authors:  Sarah J Paulsen; Mette M Rosenkilde; Jesper Eugen-Olsen; Thomas N Kledal
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6.

Authors:  T Hideshima; D Chauhan; G Teoh; N Raje; S P Treon; Y T Tai; Y Shima; K C Anderson
Journal:  Clin Cancer Res       Date:  2000-03       Impact factor: 12.531

4.  Same structure, different function crystal structure of the Epstein-Barr virus IL-10 bound to the soluble IL-10R1 chain.

Authors:  Sung Il Yoon; Brandi C Jones; Naomi J Logsdon; Mark R Walter
Journal:  Structure       Date:  2005-04       Impact factor: 5.006

5.  KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells.

Authors:  J T Stine; C Wood; M Hill; A Epp; C J Raport; V L Schweickart; Y Endo; T Sasaki; G Simmons; C Boshoff; P Clapham; Y Chang; P Moore; P W Gray; D Chantry
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

6.  HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines.

Authors:  D J Dairaghi; R A Fan; B E McMaster; M R Hanley; T J Schall
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

Review 7.  Human gammaherpesvirus cytokines and chemokine receptors.

Authors:  John Nicholas
Journal:  J Interferon Cytokine Res       Date:  2005-07       Impact factor: 2.607

8.  Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.

Authors:  N Nishimoto; M Sasai; Y Shima; M Nakagawa; T Matsumoto; T Shirai; T Kishimoto; K Yoshizaki
Journal:  Blood       Date:  2000-01-01       Impact factor: 22.113

9.  Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

Authors:  K D Jones; Y Aoki; Y Chang; P S Moore; R Yarchoan; G Tosato
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

10.  A single amino acid determines the immunostimulatory activity of interleukin 10.

Authors:  Y Ding; L Qin; S V Kotenko; S Pestka; J S Bromberg
Journal:  J Exp Med       Date:  2000-01-17       Impact factor: 14.307

View more
  9 in total

Review 1.  Anti-inflammatory cytokines in sickle cell disease.

Authors:  Adekunle E Alagbe; Igor F Domingos; Adekunle D Adekile; Maria H S L Blotta; Magnun N N Santos
Journal:  Mol Biol Rep       Date:  2022-01-09       Impact factor: 2.316

2.  Kaposi's sarcoma-associated herpesvirus induces rapid release of angiopoietin-2 from endothelial cells.

Authors:  Feng-Chun Ye; Fu-Chun Zhou; Stanley Nithianantham; Bala Chandran; Xiao-Lan Yu; Aaron Weinberg; Shou-Jiang Gao
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

3.  Human herpesviridae methods of natural killer cell evasion.

Authors:  Carl I Odom; David C Gaston; James M Markert; Kevin A Cassady
Journal:  Adv Virol       Date:  2012-07-08

4.  Immune camouflage: relevance to vaccines and human immunology.

Authors:  Anne S De Groot; Lenny Moise; Rui Liu; Andres H Gutierrez; Ryan Tassone; Chris Bailey-Kellogg; William Martin
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Epstein-Barr virus infection in chronically inflamed periapical granulomas.

Authors:  Kosuke Makino; Osamu Takeichi; Keisuke Hatori; Kenichi Imai; Kuniyasu Ochiai; Bunnai Ogiso
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

6.  Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency.

Authors:  Chris Hughes; Angelica Sette; Michael Seed; Fulvio D'Acquisto; Antonio Manzo; Tonia L Vincent; Ngee Han Lim; Ahuva Nissim
Journal:  Arthritis Res Ther       Date:  2014-07-16       Impact factor: 5.156

Review 7.  Strategies of Epstein-Barr virus to evade innate antiviral immunity of its human host.

Authors:  Manuel Albanese; Takanobu Tagawa; Wolfgang Hammerschmidt
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

8.  Professional antigen presenting cells in human herpesvirus 8 infection.

Authors:  Emilee R Knowlton; Lauren M Lepone; Jun Li; Giovanna Rappocciolo; Frank J Jenkins; Charles R Rinaldo
Journal:  Front Immunol       Date:  2013-01-21       Impact factor: 7.561

Review 9.  Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

Authors:  Santa Rasa; Zaiga Nora-Krukle; Nina Henning; Eva Eliassen; Evelina Shikova; Thomas Harrer; Carmen Scheibenbogen; Modra Murovska; Bhupesh K Prusty
Journal:  J Transl Med       Date:  2018-10-01       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.